{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:59:26Z","timestamp":1775869166293,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["23038.005289\/2017-88"],"award-info":[{"award-number":["23038.005289\/2017-88"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302622\/2015-2 and 304747\/2018-1"],"award-info":[{"award-number":["302622\/2015-2 and 304747\/2018-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006417","name":"Fundo de Apoio ao Ensino, \u00e0 Pesquisa e Extens\u00e3o, Universidade Estadual de Campinas","doi-asserted-by":"publisher","award":["7517\/2018"],"award-info":[{"award-number":["7517\/2018"]}],"id":[{"id":"10.13039\/501100006417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00345-020-03294-w","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T14:04:46Z","timestamp":1591106686000},"page":"1187-1194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-gu\u00e9rin association"],"prefix":"10.1007","volume":"39","author":[{"given":"Isis G. A.","family":"Kiehl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Riccetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C. C.","family":"Salustiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V.","family":"Ossick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa B.","family":"Assalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-414X","authenticated-orcid":false,"given":"Leonardo O.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"3","key":"3294_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2017) EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 71(3):447\u2013461","journal-title":"Eur Urol"},{"issue":"3","key":"3294_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","volume":"170","author":"A B\u00f6Hle","year":"2003","unstructured":"B\u00f6Hle A, Brandau S (2003) Immune mechanisms in bacillus calmette-guerin immunotherapy for superficial bladder cancer. J Urol 170(3):964\u2013969","journal-title":"J Urol"},{"key":"3294_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-5347(02)80294-4","volume":"167","author":"A Morales","year":"2002","unstructured":"Morales A, Eidinger D, Bruce AW (2002) Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors. J Urol 167:891\u20134","journal-title":"J Urol"},{"key":"3294_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mrfmmm.2014.05.005","volume":"768","author":"N Di Santo","year":"2014","unstructured":"Di Santo N, Ehrisman J (2014) A functional perspective of nitazoxanide as a potential anticancer drug. Mutat Res 768:16\u201321","journal-title":"Mutat Res"},{"issue":"9","key":"3294_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/1535-7163.MCT-12-1243","volume":"12","author":"H Fan-Minogue","year":"2013","unstructured":"Fan-Minogue H, Bodapati S, Solow-Cordero D, Fan A, Paulmurugan R, Massoud TF et al (2013) A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. Mol Cancer Ther 12(9):1896\u20131905","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"3294_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.juro.2014.08.106","volume":"193","author":"KL Ferrari","year":"2015","unstructured":"Ferrari KL, de Camargo JA, Rocha GZ, Carvalheira JBC, Saad MJA, Billis A et al (2015) Intravesical bacillus calmette-gu\u00e9rin efficiently reduces p70S6K1 but Not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer. J Urol 193(2):682\u2013689","journal-title":"J Urol"},{"issue":"1","key":"3294_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12032-017-1067-2","volume":"35","author":"GR Passos","year":"2018","unstructured":"Passos GR, Camargo JA, Ferrari KL, Saad MJA, de Mattos AC, Reis LO (2018) Intravesical Thalidomide boosts bacillus Calmette-Gu\u00e9rin (BCG) in non-muscle invasive bladder cancer treatment. Med Oncol 35(1):3","journal-title":"Med Oncol"},{"issue":"2","key":"3294_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.juro.2011.10.022","volume":"187","author":"LO Reis","year":"2012","unstructured":"Reis LO, Ferreira U, Billis A, Cagnon VHA, F\u00e1varo WJ (2012) Anti-Angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus calmette-gu\u00e9rin immunotherapy for nonmuscle invasive bladder cancer. J Urol 187(2):438\u2013445","journal-title":"J Urol"},{"key":"3294_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/S0102-86502011000800019","volume":"26","author":"LO Reis","year":"2011","unstructured":"Reis LO, Sopena JMG, F\u00e1varo WJ, Martin MC, Sim\u00e3o AFL, dos Reis RB et al (2011) Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool. Acta Cir\u00fargica Brasileira. 26:106\u2013110","journal-title":"Acta Cir\u00fargica Brasileira."},{"issue":"4","key":"3294_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00345-010-0545-3","volume":"28","author":"LO Reis","year":"2010","unstructured":"Reis LO, F\u00e1varo WJ, Ferreira U, Billis A, Fazuoli MG, Cagnon VHA (2010) Evolution on experimental animal model for upper urothelium carcinogenesis. World J Urol 28(4):499\u2013505","journal-title":"World J Urol"},{"issue":"3","key":"3294_CR11","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1016\/j.clgc.2017.10.019","volume":"16","author":"JA Camargo","year":"2018","unstructured":"Camargo JA, Passos GR, Ferrari KL, Billis A, Saad MJA, Reis LO (2018) Intravesical immunomodulatory imiquimod enhances bacillus calmette-gu\u00e9rin downregulation of nonmuscle-invasive bladder cancer. Clin Genitourin Cancer 16(3):e587\u2013e593. https:\/\/doi.org\/10.1016\/j.clgc.2017.10.019","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"3294_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jat.2550050202","volume":"5","author":"JR Murphy","year":"1985","unstructured":"Murphy JR, Friedmann J-C (1985) Pre-clinical toxicology of nitazoxanide\u2013a new antiparasitic compound. J Appl Toxicol 5(2):49\u201352","journal-title":"J Appl Toxicol"},{"issue":"6","key":"3294_CR13","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s00436-015-4412-4","volume":"114","author":"C Liu","year":"2015","unstructured":"Liu C, Zhang H, Yin J, Hu W (2015) In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis. Parasitol Res 114(6):2213\u20132222","journal-title":"Parasitol Res"},{"issue":"2","key":"3294_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/106689690501300203","volume":"13","author":"R Montironi","year":"2005","unstructured":"Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13(2):143\u2013153","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"3294_CR15","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2615","volume":"12","author":"VJ Tuominen","year":"2010","unstructured":"Tuominen VJ, Ruotoistenm\u00e4ki S, Viitanen A, Jumppanen M, Isola J (2010) ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12(4):R56","journal-title":"Breast Cancer Res"},{"key":"3294_CR16","doi-asserted-by":"crossref","unstructured":"Boegemann M, Aydin AM, Bagrodia A, Krabbe L-M. Prospects and progress of immunotherapy for bladder cancer. Expert Opinion on Biological Therapy. 2017;1\u201315.","DOI":"10.1080\/14712598.2017.1366445"},{"issue":"3","key":"3294_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00345-014-1329-y","volume":"33","author":"LO Reis","year":"2015","unstructured":"Reis LO, Ferrari K, Zamuner M, Rocha GZ, Billis A, F\u00e1varo WJ (2015) Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model. World J Urol 33(3):413\u2013419. https:\/\/doi.org\/10.1007\/s00345-014-1329-y","journal-title":"World J Urol"},{"issue":"12","key":"3294_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.1349-7006.1990.tb02677.x","volume":"81","author":"T Kotake","year":"1990","unstructured":"Kotake T, Saiki S, Kinouchi T, Shiku H, Nakayama E (1990) Detection of the c-myc gene product in urinary bladder cancer. Jpn J Cancer Res 81(12):1198\u20131201. https:\/\/doi.org\/10.1111\/j.1349-7006.1990.tb02677.x","journal-title":"Jpn J Cancer Res"},{"key":"3294_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00678-1","author":"R Stec","year":"2019","unstructured":"Stec R, Cierniak S, Lubas A et al (2019) Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer. Pathol Oncol Res. https:\/\/doi.org\/10.1007\/s12253-019-00678-1","journal-title":"Pathol Oncol Res."},{"key":"3294_CR20","doi-asserted-by":"crossref","unstructured":"Elwy AE, Elsaba TM, Abd Elzaher AR, Nassar MI. Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.\u00a0Asian Pac J Cancer Prev. 2019;20(12):3735\u20133746. 10.31557\/APJCP.2019.20.12.3735.","DOI":"10.31557\/APJCP.2019.20.12.3735"},{"issue":"6","key":"3294_CR21","doi-asserted-by":"publisher","first-page":"e0127908","DOI":"10.1371\/journal.pone.0127908","volume":"10","author":"F Massari","year":"2015","unstructured":"Massari F, Bria E, Ciccarese C et al (2015) Prognostic value of beta-tubulin-3 and c-Myc in muscle invasive urothelial carcinoma of the bladder. PLoS One. 10(6):e0127908. https:\/\/doi.org\/10.1371\/journal.pone.0127908","journal-title":"PLoS One."},{"issue":"3","key":"3294_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/ijms17030271","volume":"17","author":"D Conconi","year":"2016","unstructured":"Conconi D, Sala E, Bovo G et al (2016) Using copy number alterations to identify new therapeutic targets for bladder carcinoma. Int J Mol Sci. 17(3):271. https:\/\/doi.org\/10.3390\/ijms17030271","journal-title":"Int J Mol Sci."},{"issue":"10","key":"3294_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00345-019-02894-5","volume":"37","author":"LO Reis","year":"2019","unstructured":"Reis LO (2019) Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future. World J Urol 37(10):1999\u20132000. https:\/\/doi.org\/10.1007\/s00345-019-02894-5","journal-title":"World J Urol"},{"key":"3294_CR24","doi-asserted-by":"crossref","unstructured":"Di Santo N, Ehrisman J. Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose? Cancers. 2013;5(3):1163\u201376.","DOI":"10.3390\/cancers5031163"},{"issue":"2","key":"3294_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<169::AID-IJC13>3.0.CO;2-F","volume":"84","author":"F Christoph","year":"1999","unstructured":"Christoph F, Schmidt B, Schmitz-Dr\u00e4ger BJ, Schulz WA (1999) Over-expression and amplification of the c-myc gene in human urothelial carcinoma. Int J Cancer 84(2):169\u2013173","journal-title":"Int J Cancer"},{"issue":"1","key":"3294_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hep.29183","volume":"66","author":"P Liu","year":"2017","unstructured":"Liu P, Ge M, Hu J, Li X, Che L, Sun K et al (2017) A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis. Hepatology 66(1):167\u2013181","journal-title":"Hepatology"},{"issue":"29","key":"3294_CR27","doi-asserted-by":"publisher","first-page":"11988","DOI":"10.1073\/pnas.1310230110","volume":"110","author":"M Pourdehnad","year":"2013","unstructured":"Pourdehnad M, Truitt ML, Siddiqi IN, Ducker GS, Shokat KM, Ruggero D (2013) Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci 110(29):11988\u201311993","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3294_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-14-0792","volume":"14","author":"W Senkowski","year":"2015","unstructured":"Senkowski W, Zhang X, Olofsson MH, Isacson R, Hoglund U, Gustafsson M et al (2015) Three-dimensional cell culture-based screening identifies the anthelmintic drug nitazoxanide as a candidate for treatment of colorectal cancer. Mol Cancer Ther 14(6):1504\u20131516","journal-title":"Mol Cancer Ther"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03294-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:13:38Z","timestamp":1622592818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03294-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3294"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03294-w","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The local research ethics committee approved the protocol (n\u00ba 4540-1\/2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving animals"}}]}}